The distinct novelty of our study is that it combines these complementary endpoints to delineate a coherent cytoprotective profile for a Lir in cardiomyocytes, thereby refining the mechanistic context for GLP-1R signalling in diabetic cardiomyopathy. This evidence concerns the gene GLP1R and diabetic cardiomyopathy.